These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1171809)

  • 21. [Effects of beta-phenylethylamine derivatives on the central nervous system. (5) The effect of intracerebral administration of tyramine on head twitching in mice pre-treated with isocarboxazid].
    Sakurada S
    Nihon Yakurigaku Zasshi; 1975 Nov; 71(8):779-87. PubMed ID: 130286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)].
    Fukushima N
    Hokkaido Igaku Zasshi; 1975 Jul; 50(4):369-85. PubMed ID: 1240080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of cholecystokinin octapeptide on ethanol-induced changes in motor activity and in dopamine metabolism in the nucleus accumbens of the rat brain].
    Medvedeva OF; Sudakova SK; Anokhina IP; Kianmaa K
    Eksp Klin Farmakol; 1996; 59(6):44-7. PubMed ID: 9181874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of reserpine and 6-hydroxydopamine on the concentrations of some arylakylamines in rat brain.
    Boulton AA; Juorio AV; Philips SR; Wu PH
    Br J Pharmacol; 1977 Jan; 59(1):209-14. PubMed ID: 837000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Central effect of beta-phenyl ethylamines derivatives. 1. Effect of intracerebral administration of beta-phenylethylamine derivatives on behavioral changes in mice].
    Sakurada S; Tadano T; Shima K; Kisara K
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):619-25. PubMed ID: 4676607
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of tricyclic antidepressants and neuroleptics on the peripheral and central action of norepinephrine in reserpine-treated mice.
    Nakamura M; Fukushima H
    Eur J Pharmacol; 1976 Aug; 38(2):343-8. PubMed ID: 954847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of the adrenergic mechanism.
    Pfeifer AK
    J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4153869
    [No Abstract]   [Full Text] [Related]  

  • 30. Modification by metaraminol of reserpine action on noradrenaline stores in the rat heart.
    Manara L; Bareggi SR
    Eur J Pharmacol; 1969 Jul; 7(1):115-7. PubMed ID: 5821799
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in the development of central noradrenaline neurones following neonatal administration of 6-hydroxydopamine.
    Jonsson G; Pycock C; Fuxe K; Sachs C
    J Neurochem; 1974 Mar; 22(3):419-26. PubMed ID: 4829965
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of behavioral changes in cats treated with intracerebroventricular 6-hydroxydopamine and reserpine.
    Beleslin DB; Samardzić R; Krstić SK; Mićić D; Terzić B
    Brain Res Bull; 1981 Mar; 6(3):285-7. PubMed ID: 7194723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal rhythms in noradrenaline turnover and motility after reserpine and 6-hydroxydopamine.
    Lemmer B; Wenda K
    Pharmacol Biochem Behav; 1979 Mar; 10(3):361-8. PubMed ID: 572061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of evidence for the involvement of catecholaminergic mechanisms in the behavioral anti-methamphetamine effect of L-histidine in the mouse.
    Itoh Y; Oishi R; Nishibori M; Saeki K; Furuno K; Fukuda T; Araki Y
    Pharmacol Biochem Behav; 1986 Mar; 24(3):571-4. PubMed ID: 3703891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamine.
    Borison RL; Sabelli HC; Maple PJ; Havdala HS; Diamond BI
    Psychopharmacology (Berl); 1978 Dec; 59(3):259-62. PubMed ID: 104329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different mechanisms of drug-induced release of noradrenaline and its congeners alpha-methylnoradrenaline and metaraminol.
    Carlsson A; Waldeck B
    Eur J Pharmacol; 1968 Sep; 4(2):165-8. PubMed ID: 5723998
    [No Abstract]   [Full Text] [Related]  

  • 37. 2-mercaptobenzothiazole, an inhibitor of dopamine beta-hydroxylase.
    Johnson GA; Boukma SJ; Platz PA
    J Pharm Pharmacol; 1970 Sep; 22(9):710-2. PubMed ID: 4394766
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and norepinephrine-depleting activity of some esters of metaraminol.
    Saari WS; Raab AW; Miller CS; Hoffman WF; Engelhardt EL
    J Med Chem; 1971 Dec; 14(12):1230-3. PubMed ID: 5116241
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue levels of metaraminol and its metabolite, alpha-methylnorepinephrine, in control and 6-hydroxydopamine-pretreated guinea pigs.
    Fuller RW; Snoddy HD; Perry KW
    Life Sci; 1981 Sep; 29(12):1271-5. PubMed ID: 6795404
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of reserpine and metaraminol on excretion of homovanilic acid and 3-methoxy-4-hydroxyphenolglycol in the rat.
    Kopin IJ; Weise VK
    Biochem Pharmacol; 1968 Jul; 17(7):1461-4. PubMed ID: 5659789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.